Table 5.

OR^a estimates related to admission to the ICU^b among those who tested positive for SARS-CoV-2 (N=1508), stratified by gender and age group (1 model for each variable).

Variable and category		Male		Female
		Age 45-59 years (n=370, 24.5%), OR (95% CI)c	Age 60-74 years (n=748, 49.6%), OR (95% CI)c	Age 45-59 years (n=133, 8.8%), OR (95% CI)c	Age 60-74 years (n=257, 17.1%), OR (95% CI)c
CCId
	0	Reference	Reference	Reference	Reference
	1	1.39 (1.04-1.86)e	1.15 (0.94-1.42)	1.06 (0.66-1.70)	1.25 (0.91-1.73)
	2-3	1.32 (0.85-2.05)	1.04 (0.82-1.32)	2.46 (1.39-4.36)e	1.89 (1.32-2.71)e
	4+	1.91 (0.83-4.39)	1.09 (0.77-1.54)	1.33 (0.17-10.35)	2.35 (1.32-4.19)e
Oncological disease		1.44 (0.74-2.80)	0.86 (0.62-1.20)	0.91 (0.28-2.94)	0.97 (0.55-1.71)
Cardiovascular disease		1.58 (1.09-2.30)e	0.84 (0.68-1.03)	2.02 (1.08-3.76)e	1.23 (0.87-1.75)
Respiratory disease		1.53 (0.96-2.45)	0.84 (0.63-1.14)	1.92 (0.81-4.51)	1.53 (1.01-2.32)e
Myocardial infarction		2.05 (1.08-3.86)e	1.04 (0.77-1.40)	2.00 (0.25-15.85)	1.75 (0.95-3.22)
Heart failure		N/Af	1.16 (0.66-2.06)	N/A	1.39 (0.52-3.69)
Cerebrovascular disease		1.39 (0.55-3.50)	0.74 (0.50-1.08)	1.08 (0.14-8.21)	0.94 (0.49-1.80)
Diabetes		1.43 (0.98-2.11)	1.58 (1.31-1.92)e	2.58 (1.51-4.42)e	2.14 (1.57-2.92)e

^aOR: odds ratio.

^bICU: intensive care unit.

^cEstimates adjusted for age and the month of the first swab.

^dCCI: Charlson Comorbidity Index.

^eSignificant estimates (95% confidence level).

^fN/A: not applicable.